Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Editorial Board337
Cellular stress and macrophage activation99
Differential immune responses behind different celiac disease manifestations93
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells84
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity82
COVID-19 in Latin America: Clinical and immunological insights, vaccine development, and lessons for pandemic preparedness80
Exploiting antifungal immunity in the clinical context77
Three’s company: The cooperative signals behind the differentiation of Th9 cells76
Editorial Board68
Aging of lymphoid stromal architecture impacts immune responses66
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges61
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity60
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi56
Microbial metabolites and immunotherapy: Basic rationale and clinical indications54
Pyroptosis modulation by bacterial effector proteins54
Local and Cell-intrinsic complement: The new player in cancer progression46
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity44
Immunity to pathogenic fungi in the eye44
IL-1 family members as regulators of lymphoid type-2 immunity in cancer43
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease43
Pyroptosis: A road to next-generation cancer immunotherapy39
The noncanonical inflammasome-induced pyroptosis and septic shock39
Therapeutic immune tolerance for central nervous system autoimmune diseases – Prospects, challenges and pitfalls38
Pyroptosis and the cellular consequences of gasdermin pores38
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity37
Western diet influences on microbiome and carcinogenesis36
Immunity to fungi: Editorial overview32
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment32
Autoimmune diabetes and targets for immunomodulation32
Interplay between the complement system and other immune pathways in the tumor microenvironment32
Neuroimmune interactions between itch neurons and skin microbes32
Interleukin-1β and cancer immune response31
The evolving biology of cross-presentation31
The paradox of aging: Aging-related shifts in T cell function and metabolism31
Adaptive NK cell response to human cytomegalovirus: Facts and open issues29
Thymus aging and immune reconstitution, progresses and challenges28
TREM2: A new player in the tumor microenvironment28
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases27
Sialic acid and Siglec receptors in tumor immunity and immunotherapy26
Antigen discovery for the development of cancer immunotherapy26
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy26
The multifaceted role of B lymphocytes in type 1 diabetes25
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination25
Introduction to the Special Issue: Nutrition, microbiota and immunity25
Diverse IL-9-secreting T helper cells direct responses in the allergic lung25
T cell control of SARS-CoV-2: When, which, and where?25
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs25
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?24
T cell fate decisions during memory cell generation with aging24
Editorial Board24
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders24
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity24
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity24
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy24
Proteostasis in T cell aging22
The complement system in clinical oncology: Applications, limitations and challenges22
Better safe than sorry: Naive T-cell dynamics in healthy ageing21
The glycoimmune landscape in health and disease21
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice21
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy21
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells21
Epigenetic and transcriptional control of gasdermins20
Human thymus in health and disease: Recent advances in diagnosis and biology19
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions18
Global aspects of celiac disease and food allergy18
The multisensory regulation of unconventional T cell homeostasis18
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review18
Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging17
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation17
A major mechanism for immunomodulation: Dietary fibres and acid metabolites17
Editorial: Autoimmune diseases of the central nervous system17
New insights into Th9 cells in inflammatory bowel diseases17
Harnessing complement biomarkers for precision cancer care17
The role of non-cancer cell infections in oncolytic virus therapy17
Siglecs as modulators of macrophage phenotype and function16
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond16
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases16
Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches16
Editorial Board16
Microbial gasdermins: More than a billion years of pyroptotic-like cell death16
Unconventional protein secretion by gasdermin pores16
Durability of immune responses to SARS-CoV-2 infection and vaccination15
Macronutrient availability and immune cell responses15
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC15
Pyroptosis-induced inflammation and tissue damage15
Systems analysis of innate and adaptive immunity in Long COVID15
The role of ILC subsets in cancer15
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies14
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation14
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond14
Editorial Board14
Integrating immunopeptidome analysis for the design and development of cancer vaccines14
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas14
The gut-brain vascular axis in neuroinflammation13
Regulatory T cells in allergic inflammation13
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions13
Complement regulation in tumor immune evasion13
Galectins and Host–Pathogen Interactions: The roles in viral infections13
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences12
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies12
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives12
Chronic Chagas disease and type 2 diabetes comorbidity. The scenario in which two differently driven inflammatory mechanisms meet12
Systems analysis of human innate immunity in COVID-1912
The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function12
To die or not to die: Gasdermins in intestinal health and disease12
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging11
The role of sialoglycans in modulating dendritic cell function and tumour immunity11
Access to CAR-T therapy in Latin America: Barriers, gaps, and pathways forward11
Editorial Board11
Latest insights into oncolytic viro-immunotherapy with vesicular stomatitis virus11
Immunity to fungi in the lung11
The origins, manifestations, and potential treatments of allergic disorders10
Toolkit for mapping the clonal landscape of tumor-infiltrating B cells10
Editorial Board10
Uncovered role of Th9 and IL-9 in rheumatoid arthritis: Current status and future directions10
Systems biology of B cells in COVID-1910
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging10
Diffuse neuropsychiatric lupus: Clinical evidence, immune-mediated mechanisms, and therapeutic insights10
0.1769700050354